These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 30543891

  • 21. Characterization and quantitation of clarithromycin polymorphs by powder X-ray diffractometry and solid-state NMR spectroscopy.
    Tozuka Y, Ito A, Seki H, Oguchi T, Yamamoto K.
    Chem Pharm Bull (Tokyo); 2002 Aug; 50(8):1128-30. PubMed ID: 12192153
    [Abstract] [Full Text] [Related]

  • 22. Role of moisture on the physical stability of polymorphic olanzapine.
    Paisana MC, Wahl MA, Pinto JF.
    Int J Pharm; 2016 Jul 25; 509(1-2):135-148. PubMed ID: 27234701
    [Abstract] [Full Text] [Related]

  • 23. IR spectroscopy together with multivariate data analysis as a process analytical tool for in-line monitoring of crystallization process and solid-state analysis of crystalline product.
    Pöllänen K, Häkkinen A, Reinikainen SP, Rantanen J, Karjalainen M, Louhi-Kultanen M, Nyström L.
    J Pharm Biomed Anal; 2005 Jun 15; 38(2):275-84. PubMed ID: 15925219
    [Abstract] [Full Text] [Related]

  • 24. Study and characterization of crystalline hydrate/polymorph forms of 5,11-dihydro-11-ethyl-5-methyl-8-(2-(1-oxido-4-quinolinyl)ethyl-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepin-6-one by solid-state NMR and solution NMR.
    Gonnella NC, Smoliga JA, Campbell S, Busacca CA, Cerreta M, Varsolona R, Norwood DL.
    J Pharm Biomed Anal; 2010 Apr 06; 51(5):1047-53. PubMed ID: 20018474
    [Abstract] [Full Text] [Related]

  • 25. Analysis of chlorthalidone polymorphs in raw materials and tablets and the effect of forms I and II on the dissolution properties of drug products.
    Bonfilio R, Leal JS, Santos OM, Pereira GR, Doriguetto AC, de Araújo MB.
    J Pharm Biomed Anal; 2014 Jan 06; 88():562-70. PubMed ID: 24216278
    [Abstract] [Full Text] [Related]

  • 26. Solid state characterization of olanzapine polymorphs using vibrational spectroscopy.
    Ayala AP, Siesler HW, Boese R, Hoffmann GG, Polla GI, Vega DR.
    Int J Pharm; 2006 Dec 01; 326(1-2):69-79. PubMed ID: 16949223
    [Abstract] [Full Text] [Related]

  • 27. Effect of polymers in moisture sorption and physical stability of polymorphic olanzapine.
    Paisana MC, Wahl MA, Pinto JF.
    Eur J Pharm Sci; 2017 Jan 15; 97():257-268. PubMed ID: 27908675
    [Abstract] [Full Text] [Related]

  • 28. Characterization of nicergoline polymorphs crystallized in several organic solvents.
    Malaj L, Censi R, Capsoni D, Pellegrino L, Bini M, Ferrari S, Gobetto R, Massarotti V, Di Martino P.
    J Pharm Sci; 2011 Jul 15; 100(7):2610-22. PubMed ID: 21254066
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Crystallographic, thermal and spectroscopic characterization of a ciprofloxacin saccharinate polymorph.
    Romañuk CB, Garro Linck Y, Chattah AK, Monti GA, Cuffini SL, Garland MT, Baggio R, Manzo RH, Olivera ME.
    Int J Pharm; 2010 May 31; 391(1-2):197-202. PubMed ID: 20214961
    [Abstract] [Full Text] [Related]

  • 32. Four new polymorphic forms of suplatast tosilate.
    Nagai K, Ushio T, Miura H, Nakamura T, Moribe K, Yamamoto K.
    Int J Pharm; 2014 Jan 02; 460(1-2):83-91. PubMed ID: 24211359
    [Abstract] [Full Text] [Related]

  • 33. Thermal, spectroscopic, and ab initio structural characterization of carprofen polymorphs.
    Bruni G, Gozzo F, Capsoni D, Bini M, Macchi P, Simoncic P, Berbenni V, Milanese C, Girella A, Ferrari S, Marini A.
    J Pharm Sci; 2011 Jun 02; 100(6):2321-32. PubMed ID: 21246561
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Variable-temperature X-ray powder diffraction analysis of the crystal transformation of the pharmaceutically preferred polymorph C of mebendazole.
    de Villiers MM, Terblanche RJ, Liebenberg W, Swanepoel E, Dekker TG, Song M.
    J Pharm Biomed Anal; 2005 Jul 01; 38(3):435-41. PubMed ID: 15925244
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Characterization, selection, and development of an orally dosed drug polymorph from an enantiotropically related system.
    Katrincic LM, Sun YT, Carlton RA, Diederich AM, Mueller RL, Vogt FG.
    Int J Pharm; 2009 Jan 21; 366(1-2):1-13. PubMed ID: 18824090
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Polymorphism of cellulose I family: reinvestigation of cellulose IVI.
    Wada M, Heux L, Sugiyama J.
    Biomacromolecules; 2004 Jan 21; 5(4):1385-91. PubMed ID: 15244455
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.